Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michelle Penney"'
Autor:
Winifred Badaiki, Evelyn Pyper, Kendra Lester, Janelle Skeard, Michelle Penney, Janey Shin, Brenda Fisher, Huong Hew, Susanne Gulliver, Wayne Gulliver, Proton Rahman
Publikováno v:
International Journal of Population Data Science, Vol 7, Iss 1 (2022)
The Janssen and Newfoundland and Labrador Health Innovation Partnership (JANL-HIP) was established to carry out Real-World Evidence (RWE) projects to generate evidence about disease pathways, healthcare delivery, the effects of clinical interventions
Externí odkaz:
https://doaj.org/article/b822f14c00d44ed382be84d8483b3a57
Autor:
Winifred Badaiki, Michelle Penney, Evelyn Pyper, Kendra Lester, Janelle Skeard, Janey Shin, Brenda Fisher, Susanne Gulliver, Wayne Gulliver, Proton Rahman
Publikováno v:
Journal of cutaneous medicine and surgery. 26(5)
Background Psoriasis is a chronic, immune-mediated inflammatory disease with an implied connection to psychiatric disorders. Objective This study aims to illustrate an association between psoriasis and psychiatric disorders using real world data gath
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e5e69f94e595d54871c6b9440d462a6
https://pubmed.ncbi.nlm.nih.gov/35938546
https://pubmed.ncbi.nlm.nih.gov/35938546
Publikováno v:
Dermatology (Basel, Switzerland). 238(3)
Background: The incidence of cutaneous malignant melanoma continues to increase worldwide and in Canada. It is unclear whether the increase in incidence and clinical characteristic trends of cutaneous malignant melanoma are similar in the province of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::343ef9b13bb951d361bb84c5e729892f
https://pubmed.ncbi.nlm.nih.gov/34610598
https://pubmed.ncbi.nlm.nih.gov/34610598
Autor:
Sonia Montmayeur, Rebecca J Power, Michelle Penney, Susanne Gulliver, Russel Burge, Wayne Gulliver
Publikováno v:
The Journal of dermatological treatment. 33(1)
Introduction: Data on real-world experiences for patients treated with ixekizumab is currently limited.Objectives: Describe characteristics of ixekizumab-treated psoriasis patients and provide evidence of clinical outcomes using disease severity scor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c8aecce024e8e62f2446f8830c6c2b3
https://pubmed.ncbi.nlm.nih.gov/32319327
https://pubmed.ncbi.nlm.nih.gov/32319327